Platelet-monoamine-oxidase activity predicts response to lithium in manic-depressive illness.
Lancet, 1977/12/24-1977/12/31;2(8052-8053):1325-7.
Sullivan JL, Cavenar JO Jr, Maltbie A, Stanfield C
PMID: 74733
Impact factor: 202.731
Abstract
Platelet-monoamine-oxidase activity predicts treatment response to lithium in manic-depressive illness. In the treatment-responsive group enzyme activity is similar to that in normal controls, whereas in the treatment-refractory group enzyme activity is significantly less than both control and treatment-responsive groups.
MeSH terms
More resources
EndNote: Download